Results 201 to 210 of about 382,720 (316)

The specific contributions of factor H and factor I in controlling fluid phase activation of the alternative complement pathway. [PDF]

Sci Rep
Turner NA, Moake JL.
europepmc   +1 more source

INCREASED FREQUENCY OF THE BfF GENE IN THE IDIOPATHIC NEPHROTIC SYNDROME (INS): STUDIES OF THE ALTERNATIVE COMPLEMENT PATHWAY IN INS [PDF]

, 1980
R H McLean, T. L. Kennedy, Mark Ballow, Norman J. Siegel   +3 more
openalex   +1 more source

Flexible Leaf‐Like Fuel Cell From Plasmonic Janus Nanosheet

Advanced Functional Materials, EarlyView.
A flexible leaf‐like fuel cell is fabricated by conductive gold nanowire sponge‐supported plasmonic Janus nanosheet, which can generate a power of 8.93 mW cm⁻2 with less than 10% performance deterioration even being bent or twisted. Further assembly in a tree‐like layout demonstrates omnidirectional light harvesting capability and wind resistance ...
Yifeng Huang, Qianqian Shi, Siyuan Liu, Wenlong Cheng   +3 more
wiley   +1 more source

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection. [PDF]

Front Immunol
Avraham M, Sinkovits G, Hurler L, Prohászka Z, Fishelson Z.   +4 more
europepmc   +1 more source

Carbon Nanotube 3D Integrated Circuits: From Design to Applications

Advanced Functional Materials, EarlyView.
As Moore's law approaches its physical limits, carbon nanotube (CNT) 3D integrated circuits (ICs) emerge as a promising alternative due to the miniaturization, high mobility, and low power consumption. CNT 3D ICs in optoelectronics, memory, and monolithic ICs are reviewed while addressing challenges in fabrication, design, and integration.
Han‐Yang Liu, Yun Sun, Dong‐Ming Sun, Hui‐Ming Cheng   +3 more
wiley   +1 more source

High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival. [PDF]

Transplant Direct, 2020
Mező B, Reindl-Schwaighofer R, Eskandary F, Heinzel A, Wahrmann M, Doberer K, Heilos A, Bond G, Kläger J, Kozakowski N, Haslacher H, Oberbauer R, Viklický O, Hrubá P, Halloran PF, Rusai K, Prohászka Z, Böhmig GA.   +17 more
europepmc   +1 more source

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.

, 1980
J. G. P. Sissons, Michael B. A. Oldstone, Robert D. Schreiber   +2 more
openalex   +1 more source

Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. [PDF]

, 1993
R H Wang, George Phillips, M. Edward Medof, Carolyn Mold   +3 more
openalex   +1 more source

Engineering Novel DNA Nanoarchitectures for Targeted Drug Delivery and Aptamer Mediated Apoptosis in Cancer Therapeutics

Advanced Functional Materials, EarlyView.
Designer DNA Architecture‐templated Drug Conjugates (DDA‐DCs) are comprised of a DNA nanomaterial decorated with multiple drug‐loaded DNA aptamers. DDA‐DCs use a combination of multiple aptamer types, each recognizing a different membrane protein to achieve precise targeting of cancer cells.
Abhisek Dwivedy, Dhyanesh Baskaran, Gaurav Sharma, Wei Hong, Dhanush Gandavadi, Abhichart Krissanaprasit, Joonsu Han, Yusheng Liu, Zack Zimmers, Tshepo Mafokwane, Ichrak Hayah, Neha Chauhan, Mengxi Zheng, Sherwood Yao, Keith Fraser, John S. Decker, Xiaohe Jin, Hua Wang, Adam D. Friedman, Xing Wang   +19 more
wiley   +1 more source

Preferential Activation of the Alternative Pathway of Complement in Psoriatic Lesional Skin [PDF]

, 1992
Hideaki Takematsu, Hachiro Tagami
openalex   +1 more source